AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $4.172M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| UBI | Ann: Appendix 4C - quarterly | 24/04/18 | 2 | 174 | |||
|
|||||||
| UBI | Ann: Resignation of Dr Alastair Hodges | 23/04/18 | 4 | 438 | |||
|
|||||||
| UBI | First Quarter | 20/04/18 | 4 | 537 | |||
|
|||||||
| UBI | SP | 18/04/18 | 14 | 2.4K | |||
|
|||||||
| UBI | Ann: Appendix 3B | 13/04/18 | 0 | 89 | |||
|
|||||||
| UBI | Ann: Resignation of Mr Garry Chambers | 13/04/18 | 3 | 533 | |||
|
|||||||
| UBI | Ann: Expiry of Unlisted Options | 03/04/18 | 0 | 82 | |||
|
|||||||
| UBI | Ann: Change of Director's Interest Notice | 19/03/18 | 0 | 131 | |||
|
|||||||
See All Discussions
ASX News